Neurology · 2005 · 77 citations · 9 references
Life SciencesGeneticsNeurologyHuman GeneticsNeurogeneticsNeuromuscular DisordersChannelopathiesCongenital Myasthenic SyndromesEnzyme DeficienciesIon Channel DisordersNeuromuscular JunctionAcetylcholine Receptor DefectsAcetylcholinesterase DeficiencyAcetylcholinesterase FunctionColq MutationsColq-related Congenital Myasthenic SyndromeEndplate Structural AbnormalitiesEphedrine TherapyPresynaptic Congenital Myasthenic Syndromes
The authors describe two patients with congenital myasthenic syndrome (CMS) with end plate acetylcholinesterase (AChE) deficiency caused by mutations in the collagenic tail (ColQ) of AChE: a homozygous C-terminal Y230S mutation in Patient 1 and Y430S and a C-terminal splice-site mutation in Patient 2. In Patient 1, a Prostigmin (neostigmine bromide) test failed to distinguish between AChE deficiency and a slow-channel CMS. Both patients responded dramatically to ephedrine therapy.
9
Kinji Ohno, Joan M. Brengman, Akira Tsujino et al. · Proceedings of the National Academy of Sciences · 1998 · 254 citations
Claire Donger, Éric Krejci, Adolf Pou Serradell et al. · The American Journal of Human Genetics · 1998 · 161 citations · Full text
The spectrum of mutations causing end-plate acetylcholinesterase deficiency
Kinji Ohno, Andrew G. Engel, Joan M. Brengman et al. · Annals of Neurology · 2000 · 120 citations
Congential Endplate acetylocholinesterase deficiency
David Hutchinson, Timothy J. Walls, Satoshi Nakano et al. · Brain · 1993 · 120 citations
Medicine, Neurology, Neuroscience +12
Three novel <i>COLQ</i> mutations and variation of phenotypic expressivity due to G240X
Yehuda Shapira, Menachem Sadeh, M.P. Bergtraum et al. · Neurology · 2002 · 52 citations